RegenerLife Watermelon

RegenerLife Watermelon

Natural Factors4.8 (484 ratings)
Format:Powder Quantity: 2 Ounce(s) · 30 servings
Goals
$41.97 $1.39 per serving

Product analysis

49 out of 100

RegenerLife Watermelon combines acetyl L-carnitine and CoQ10 for energy-related support, though benefits mainly come from evidence in selected clinical groups. Its unidentified blend makes the full mixture harder to judge.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality33

Some ingredient forms are named, but CoQ10 form details and the blend components are missing. Those gaps limit comparison with the particular preparations used in research.

Ingredient Transparency68

Amounts and several forms are disclosed. The CoQ10 form and proprietary blend composition are missing, leaving the full formula unclear.

Value For Money44

Acetyl L-carnitine offers favorable value, while CoQ10 and glutathione offer limited value at the full serving cost. There is not enough information to judge the remaining ingredient contribution.

Customer Satisfaction78

Customer ratings are very positive. The smaller review pool leaves more uncertainty, and ratings do not prove effectiveness or safety.

Product Focus35

The formula spans energy, heart and cognitive aims, with important limits from the populations and preparations studied. The unidentified blend makes its practical focus harder to judge.

Format
Powder
Container
2 Ounce(s)
Per serving
$1.39
Customer rating
4.8 · 484 ratings
Report analysis

Goals

Longevity
Impact
Moderate effect
A Ingredient FitD+ PathwaysD EvidenceA+ Formulation Logic
Coenzyme Q-10 · 300 mg

Acetyl L-carnitine relates to mitochondrial energy handling, and glutathione is an intracellular antioxidant. Coenzyme Q10 has a narrower link to visible skin aging in the supplied evidence, based on an identified water-soluble preparation. These roles offer limited support for broad longevity expectations.

How this product is rated for Longevity

Ingredient fit91

2 ingredients contribute to the saved healthy-aging assessment, with no other active ingredients reducing its focus. The contributing amounts align closely with the saved dose benchmarks.
Goal fit
2 ingredients contribute to the saved healthy-aging assessment, with no other active ingredients reducing its focus.
Dose adequacy
The contributing amounts align closely with the saved dose benchmarks.

Pathways53

The strongest recorded contribution concerns mitochondrial energy production. The saved findings reach the coverage threshold in mitochondrial energy production.
Depth
The strongest recorded contribution concerns mitochondrial energy production.
Breadth
The saved findings reach the coverage threshold in mitochondrial energy production.

Evidence49

Acetyl L-Carnitine provides the strongest qualifying evidence in the saved assessment; the relevant benefit remains limited to its reviewed outcome. The saved preparation review is limited by Coenzyme Q-10, which was not matched to the studied preparation.
Evidence strength
Acetyl L-Carnitine provides the strongest qualifying evidence in the saved assessment; the relevant benefit remains limited to its reviewed outcome.
Studied preparation
The saved preparation review is limited by Coenzyme Q-10, which was not matched to the studied preparation.

Formulation logic100

The contributing ingredients can work alone or have their required partner present. No ingredient conflicts were recorded in the saved assessment. All contributing ingredients reach the saved meaningful-dose threshold.
Partner coverage
The contributing ingredients can work alone or have their required partner present.
Conflicts
No ingredient conflicts were recorded in the saved assessment.
Effective doses
All contributing ingredients reach the saved meaningful-dose threshold.
Study evidence
Heart Health
Impact
High effect
C Ingredient FitC- PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 300 mg

Conventional CoQ10 has mixed evidence for modest blood-pressure, lipid and vascular changes in selected populations. The 300 mg per serving exceeds the exposure in a positive trial, but that does not establish greater benefit. The supplied findings do not show cardiovascular-event prevention or superior delivery from this product.

How this product is rated for Heart Health

Ingredient fit61

This is a broader formula, with only some ingredients contributing to the relevant heart-health roles. The relevant amounts provide a partial exposure match; this does not establish the effects of a studied daily regimen.
Goal fit
This is a broader formula, with only some ingredients contributing to the relevant heart-health roles.
Dose adequacy
The relevant amounts provide a partial exposure match; this does not establish the effects of a studied daily regimen.

Pathways55

The strongest recorded connection is blood-vessel function.
Depth
The strongest recorded connection is blood-vessel function.
Breadth
The contribution is concentrated in blood-vessel function, with limited breadth across other heart-health mechanisms.

Evidence98

CoQ10 has limited, selected-population evidence; the findings do not establish cardiovascular-event prevention.
Evidence strength
CoQ10 has limited, selected-population evidence; the findings do not establish cardiovascular-event prevention.
Studied preparation
The relevant preparation meets the saved preparation comparison; this does not establish finished-product equivalence or superior delivery.

Formulation logic100

No required partner is missing and no defined conflict was identified. The relevant ingredients meet the saved minimum amount comparison; that threshold is not proof of clinical effectiveness.
Partner coverage
No required partner is missing for the relevant ingredients; this does not imply added benefit from combining them.
Conflicts
No defined ingredient conflict was identified in the supplied findings.
Effective doses
The relevant ingredients meet the saved minimum amount comparison; that threshold is not proof of clinical effectiveness.
Study evidence
Brain Health
Impact
High effect
C+ Ingredient FitC- PathwaysB EvidenceA+ Formulation Logic

Acetyl L-carnitine is connected with cellular energy processes, but that mechanism does not establish better cognition in healthy adults. The supplied disease-cohort research does not support routine general brain-health benefit, and a large Alzheimer trial missed its primary outcomes. The declared amount permits an exposure comparison without establishing an effective healthy-adult cognitive dose.

How this product is rated for Brain Health

Ingredient fit66

Ingredients serving other purposes broaden the formula beyond its brain-health contribution.
Goal fit
Ingredients serving other purposes broaden the formula beyond its brain-health contribution.
Dose adequacy
The declared amounts fully meet the supplied exposure comparison, without establishing universal benefit or a daily regimen.

Pathways58

The strongest represented mechanism is cerebral energy metabolism, with the relevant ingredient limitations still applying.
Depth
The strongest represented mechanism is cerebral energy metabolism, with the relevant ingredient limitations still applying.
Breadth
The contribution concentrates on one mechanism, limiting breadth across different aspects of brain function.

Evidence76

Acetyl L-Carnitine leads the evidence finding, within the supplied population and outcome limitations.
Evidence strength
Acetyl L-Carnitine leads the evidence finding, within the supplied population and outcome limitations.
Studied preparation
The relevant preparations are accepted in the supplied comparison; this does not remove limitations in the underlying cognitive findings.

Formulation logic100

The relevant ingredients work independently or have the required partner. No configured conflict is identified in the supplied ingredient findings.
Partner coverage
The relevant ingredients work independently or have the required partner.
Conflicts
No configured conflict is identified in the supplied ingredient findings.
Effective doses
The included ingredients meet the minimum amount comparison; that threshold does not establish a proven cognitive dose.
Study evidence
Cognitive Support
Impact
High effect
C+ Ingredient FitC PathwaysB EvidenceA+ Formulation Logic
Acetyl L-Carnitine · 1500 mg

Acetyl L-carnitine has a cognitive rationale through acetyl donation and cellular energy processes. Its clinical evidence here comes from disease cohorts and cannot establish routine focus or memory improvement in healthy adults. Although the saved amount comparison fully recognizes the 1,500 mg serving, that comparison does not resolve the population limitation.

How this product is rated for Cognitive Support

Ingredient fit66

The formula contains ingredients relevant to cognitive support, with fully recognized amounts in the saved comparison. Scientific limitations still determine what those contributions can mean.
Goal fit
Relevant ingredients share the formula with other actives, so its focus extends beyond cognition.
Dose adequacy
The declared amounts receive full recognition in the saved exposure comparison; this does not establish a proven effective dose.

Pathways60

The strongest recorded area is cerebral energy buffering, without proving a clinical effect. Only one area reached the saved coverage threshold, leaving coverage concentrated.
Depth
The strongest recorded area is cerebral energy buffering, without proving a clinical effect.
Breadth
Only one area reached the saved coverage threshold, leaving coverage concentrated.

Evidence79

The evidence comparison recognizes the supplied ingredients and preparations, while selected tasks, populations and inconsistent findings limit expectations.
Evidence strength
Acetyl L-Carnitine leads the saved evidence comparison; its specific population and outcome limitations still apply.
Studied preparation
The saved preparation comparison recognizes the included materials; it does not establish benefit across all populations or outcomes.

Formulation logic100

No configured conflict was identified from the supplied facts. The recognized amounts meet the saved threshold.
Partner coverage
No missing required partner limited the recognized ingredients; this does not imply a combined benefit.
Conflicts
No configured conflict was identified from the supplied facts.
Effective doses
All ingredients included in this amount check meet its threshold; that threshold is not proof of benefit.
Study evidence
Metabolism Support
Impact
High effect
B Ingredient FitC- PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 300 mgAcetyl L-Carnitine · 1500 mg

CoQ10 participates in mitochondrial energy production, but that role does not establish that taking more raises whole-body energy expenditure. Acetyl L-carnitine has a role in fatty-acid transport, without supplied evidence of increased energy expenditure in adequately nourished adults.

How this product is rated for Metabolism Support

Ingredient fit77

CoQ10 supplies the main saved contribution through cellular energy production. Its amount meets all or part of the comparison range without establishing direct thermogenesis.
Goal fit
CoQ10 is the main ingredient recognized in the saved findings, through its role in cellular energy production.
Dose adequacy
The recognized ingredient amounts reach the saved comparison range; this does not identify a proven dose for increasing metabolic rate.

Pathways56

The strongest saved connection concerns mitochondrial energy production, principally through CoQ10; cellular energy roles do not establish increased whole-body energy expenditure.
Depth
The strongest saved connection concerns mitochondrial energy production, principally through CoQ10; cellular energy roles do not establish increased whole-body energy expenditure.
Breadth
Only the mitochondrial energy pathway reaches the saved coverage threshold.

Evidence71

CoQ10 leads the saved evidence finding, while the supplied scientific context does not establish a routine increase in whole-body energy expenditure.
Evidence strength
CoQ10 leads the saved evidence finding, while the supplied scientific context does not establish a routine increase in whole-body energy expenditure.
Studied preparation
The saved finding recognizes CoQ10 preparation coverage, but not acetyl L-carnitine; evidence for other carnitine preparations cannot be transferred.

Formulation logic100

No unmet partner requirement or configured conflict was found, and the recognized ingredients meet the saved amount threshold.
Partner coverage
The recognized ingredients have no unmet partner requirement in the saved findings; this does not establish additional benefit from combining them.
Conflicts
No configured ingredient conflict was detected in the supplied facts.
Effective doses
The recognized ingredients reach the saved amount threshold; that threshold does not establish a clinically effective thermogenic dose.
Study evidence
Mental Focus
Impact
High effect
C+ Ingredient FitC PathwaysB+ EvidenceA+ Formulation Logic
Acetyl L-Carnitine · 1500 mg

Acetyl L-carnitine supplies an acetyl donor relevant to acetylcholine synthesis and has a cognitive rationale. These mechanisms and disease-population findings do not establish improved routine attention from a single serving in healthy adults. The declared compound amount supports the saved amount finding without proving an acute focus dose.

How this product is rated for Mental Focus

Ingredient fit66

Acetyl L-carnitine has a cognitive rationale, with limited relevance to routine acute attention. The declared amount reaches the saved amount range; this is not proof of a stronger effect at higher intake.
Goal fit
Acetyl L-carnitine has a cognitive rationale, with limited relevance to routine acute attention.
Dose adequacy
The declared amount reaches the saved amount range; this is not proof of a stronger effect at higher intake.

Pathways60

Cerebral energy is the route represented in the saved finding.
Depth
Cerebral energy is the route represented in the saved finding.
Breadth
The finding is limited to the cerebral-energy route.

Evidence83

Acetyl L-carnitine has no established routine acute healthy-adult focus benefit in the supplied context.
Evidence strength
Acetyl L-carnitine has no established routine acute healthy-adult focus benefit in the supplied context.
Studied preparation
The saved preparation match is complete for the ingredients that meet its amount criterion; this does not establish consistent focus benefit.

Formulation logic100

The represented ingredients have no missing required partner in the saved finding. No specified ingredient conflict was identified in the saved findings.
Partner coverage
The represented ingredients have no missing required partner in the saved finding.
Conflicts
No specified ingredient conflict was identified in the saved findings.
Effective doses
All ingredients counted by this rule reach its minimum amount criterion; that threshold is not a clinically proven effective dose.
Study evidence

Ingredients

IngredientAmount per servingScore
Acetyl-L-Carnitine (Acetyl-L-Carnitine HCl)
1500 mg 93
Coenzyme Q10
300 mg 38
ElevATP
150 mg
Opitac (L-Glutathione)
100 mg 45
SOD B Extramel
10 mg
Superoxide Dismutase (Cucumis melo)
140 IU
Gluten Free Adults 18–50 Dairy Free Sugar Free Vegetarian
Report overview
A Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyB Value
Each serving provides 1500 mg of acetyl L-carnitine HCl, a substantial amount. The whole-product price corresponds to about $0.47 per 500 mg of acetyl L-carnitine.
How this ingredient is rated

Active Ingredient Quality & Bioavailability94

The HCl form of acetyl L-carnitine is identified. A purity or manufacturing claim is recorded in the saved facts.
ALCAR vs. Standard Carnitine Form
Acetyl L-carnitine is identified, with no other carnitine form recorded.
Advanced Sourcing and Salt Specificity
The HCl form is identified. A purity or manufacturing claim is recorded in the saved facts.

Dose, Safety & Label Transparency100

The label states 1500 mg of acetyl L-carnitine per serving, a substantial amount.
Clinical Dosage Efficacy
The serving provides 1500 mg of acetyl L-carnitine, a substantial amount.
Label Transparency and Proprietary Blends
The specific amount of acetyl L-carnitine is stated as 1500 mg per serving.

Value75

The whole-product price corresponds to about $0.47 per 500 mg of acetyl L-carnitine.
Price per 500mg Acetyl L-Carnitine
The whole-product price corresponds to about $0.47 per 500 mg of acetyl L-carnitine.
F Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyF Value
Each serving provides 100 mg of glutathione. The saved facts do not establish its form, making delivery comparisons uncertain.
How this ingredient is rated

Active Ingredient Quality & Bioavailability30

The glutathione form is not established in the saved facts. A branded source is recorded.
Delivery System & Absorption Potential
The saved facts do not identify a reduced, liposomal or other specified delivery form.
Branded Sources & Purity Markers
The saved facts record a branded glutathione source, without identifying its name.

Dose, Safety & Label Transparency68

The serving discloses 100 mg of glutathione.
Dosage Potency per Serving
The serving provides 100 mg of glutathione.
Label Transparency
The glutathione amount is individually disclosed as 100 mg per serving.

Value30

A whole-product serving costs about $1.40.
Cost Efficiency by Form
A whole-product serving costs about $1.40.
Coenzyme Q-10 · 300 mg OverallScore38
F Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyF Value
A serving lists 300 mg of CoQ10. The form is unknown in the saved facts, and a whole-product serving costs about $1.40.
How this ingredient is rated

Active Ingredient Quality & Bioavailability12

The CoQ10 form is unknown in the saved facts.
Molecular Form: Ubiquinol vs. Ubiquinone
The CoQ10 form is unknown in the saved facts, so a form-specific comparison is limited.
Formulation & Absorption Enhancers
The saved facts do not establish a named absorption-enhancing formulation or black pepper extract.

Dose, Safety & Label Transparency72

The label lists 300 mg CoQ10 per serving.
Clinical Dosage Alignment
The serving lists 300 mg CoQ10; the form is unknown.
Label Transparency & Fillers
The label lists 300 mg CoQ10 per serving; no flagged additives or standard fillers are recorded in the evaluated facts.

Value20

A whole-product serving costs about $1.40.
Price Per Effective Serving
At about $1.40 per whole-product serving, the price is high in this comparison.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  2. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  3. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R · International journal of clinical pharmacology research · 1990
    Randomized trialBrain Health forAcetyl L-Carnitine
  4. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  5. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U · International journal of clinical pharmacology research · 1990
    Randomized trial60 participantsBrain Health Mental Focus forAcetyl L-Carnitine
  6. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  7. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  8. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  9. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  10. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  11. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G · American journal of medical genetics. Part A · 2008
    Randomized trial63 participantsCognitive Support forAcetyl L-Carnitine
  12. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M · Archives of gerontology and geriatrics · 2008
    Randomized trial96 participantsCognitive Support forAcetyl L-Carnitine
  13. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
    Malaguarnera M; Vacante M; Giordano M; Pennisi G; Bella R; Rampello L; Malaguarnera M; Li Volti G; Galvano F · The American journal of clinical nutrition · 2011
    Randomized trial121 participantsEnergy forAcetyl L-Carnitine
  14. The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
    Malaguarnera M; Vacante M; Bertino G; Neri S; Malaguarnera M; Gargante MP; Motta M; Lupo L; Chisari G; Bruno CM; Pennisi G; Bella R · Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2012
    Randomized trial60 participantsEnergy forAcetyl L-Carnitine
  15. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
    Malaguarnera M; Bella R; Vacante M; Giordano M; Malaguarnera G; Gargante MP; Motta M; Mistretta A; Rampello L; Pennisi G · Scandinavian journal of gastroenterology · 2011
    Randomized trial67 participantsEnergy forAcetyl L-Carnitine
  16. A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.
    Sun Y; Shu Y; Liu B; Liu P; Wu C; Zheng R; Zhang X; Zhuang Z; Deng Y; Zheng L; Xu Q; Jiang B; Ouyang X; Gao J; Xu N; Li X; Jiang S; Liang C; Yao Y · Experimental and therapeutic medicine · 2020
    Randomized trial239 participantsEnergy forAcetyl L-Carnitine
  17. Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review.
    Kumar R; Nuñez NA; Joshi N; Joseph B; Verde A; Seshadri A; Cuellar Barboza AB; Prokop LJ; Medeiros GC; Singh B · Bipolar disorders · 2024
    Systematic reviewEnergy forAcetyl L-Carnitine
  18. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  19. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  20. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10